Height predict incident non-alcoholic fatty liver disease among general adult population in Tianjin, China, independent of body mass index, waist circumference, waist-to-height ratio, and metabolic syndrome

[1]  Shunming Zhang,et al.  Low-normal thyroid function predicts incident anemia in the general population with euthyroid status. , 2019, The Journal of clinical endocrinology and metabolism.

[2]  C. Lewis,et al.  Body mass index trajectories in young adulthood predict non‐alcoholic fatty liver disease in middle age: The CARDIA cohort study , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[3]  J. Wit,et al.  Growth hormone — past, present and future , 2018, Nature Reviews Endocrinology.

[4]  Shujuan Yang,et al.  Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study , 2017, PloS one.

[5]  M. Laakso,et al.  Short Adult Stature Predicts Impaired &bgr;-Cell Function, Insulin Resistance, Glycemia, and Type 2 Diabetes in Finnish Men , 2016, The Journal of clinical endocrinology and metabolism.

[6]  G. Meng,et al.  The Relationship Between Thyroid Function and the Prevalence of Type 2 Diabetes Mellitus in Euthyroid Subjects , 2016, The Journal of clinical endocrinology and metabolism.

[7]  J. Holst,et al.  Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference , 2016, Diabetes Care.

[8]  Kenichi Yoshida,et al.  IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner , 2016, Scientific Reports.

[9]  H. Keyvani,et al.  Body Roundness Index and Waist-to-Height Ratio are Strongly Associated With Non-Alcoholic Fatty Liver Disease: A Population-Based Study , 2016, Hepatitis monthly.

[10]  V. Rakyan,et al.  Early-life nutrition modulates the epigenetic state of specific rDNA genetic variants in mice , 2016, Science.

[11]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[12]  Farhad Zamani,et al.  Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. , 2016, World journal of gastroenterology.

[13]  Paul Welsh,et al.  Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies. , 2016, The Journal of clinical endocrinology and metabolism.

[14]  J. W. Woo Baidal,et al.  The intersection of nonalcoholic fatty liver disease and obesity , 2016, Science Translational Medicine.

[15]  M. Vickers,et al.  Developmental Programming of Nonalcoholic Fatty Liver Disease: The Effect of Early Life Nutrition on Susceptibility and Disease Severity in Later Life , 2015, BioMed research international.

[16]  Jackson T. Wright,et al.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.

[17]  V. Bloks,et al.  Maternal western diet primes non‐alcoholic fatty liver disease in adult mouse offspring , 2014, Acta physiologica.

[18]  Yan Liu,et al.  Early Life Factors and Type 2 Diabetes Mellitus , 2013, Journal of diabetes research.

[19]  N. Chalasani,et al.  Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD) , 2013, Hepatology International.

[20]  Xin Gao,et al.  Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: Consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology , 2013, Journal of diabetes.

[21]  H. Khedmat,et al.  Predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients. , 2013, Acta medica Iranica.

[22]  Y. Hiasa,et al.  Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study , 2013, Journal of Gastroenterology.

[23]  Xiaobin Wang,et al.  Epigenetics and early life origins of chronic noncommunicable diseases. , 2013, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[24]  M. Dehghani,et al.  Hip circumference, height and risk of type 2 diabetes: systematic review and meta‐analysis , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[25]  M. Abraham,et al.  Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis , 2012, Hepatology.

[26]  Youming Li,et al.  Association between Serum Growth Hormone Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study , 2012, PloS one.

[27]  R. Kitazawa,et al.  Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy. , 2012, European journal of endocrinology.

[28]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[29]  F. Arturi,et al.  Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. , 2011, The Journal of clinical endocrinology and metabolism.

[30]  Q. Anstee,et al.  How big a problem is non-alcoholic fatty liver disease? , 2011, BMJ : British Medical Journal.

[31]  M. Vogiatzi,et al.  Final adult height in children with congenital adrenal hyperplasia treated with growth hormone. , 2011, The Journal of clinical endocrinology and metabolism.

[32]  A. Deodati,et al.  Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review , 2011, BMJ : British Medical Journal.

[33]  G. Marchesini,et al.  Insulin resistance in nonalcoholic fatty liver disease. , 2010, Current pharmaceutical design.

[34]  S. Haffner,et al.  Height, ethnicity, and the incidence of diabetes: the San Antonio Heart Study. , 2009, Metabolism: clinical and experimental.

[35]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[36]  J. Newton,et al.  Non-Alcoholic Fatty Liver Disease in Older People , 2009, Gerontology.

[37]  S. Heymsfield,et al.  Scaling of human body composition to stature: new insights into body mass index. , 2007, The American journal of clinical nutrition.

[38]  Charles E McCulloch,et al.  Relaxing the rule of ten events per variable in logistic and Cox regression. , 2007, American journal of epidemiology.

[39]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[40]  K. Silventoinen.  DETERMINANTS OF VARIATION IN ADULT BODY HEIGHT , 2003, Journal of Biosocial Science.

[41]  G. Watt,et al.  Associations of height, leg length, and lung function with cardiovascular risk factors in the Midspan Family Study , 2003, Journal of epidemiology and community health.

[42]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[43]  S. Taback,et al.  Does growth-hormone supplementation affect adult height in Turner's syndrome? , 1996, The Lancet.

[44]  J. Henzen.  Publisher's note , 1979, Brain Research.

[45]  Yutaka Takahashi.  Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver. , 2012, Endocrine journal.

[46]  Jackson T. Wright,et al.  Evidence-Based Guideline for the Management of High Blood Pressure in Adults , 2012 .

[47]  R. Waterland,et al.  Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. , 2004, Nutrition.